What were the primary financial drivers for High Tide (NASDAQ:HITI) in Q2 2026?

High Tide (NASDAQ:HITI) achieved record revenue of $179.3 million, representing a 30% year-over-year increase. Growth was primarily fueled by the performance of its Canna Cabana retail network and record-setting revenue of $31.6 million from its German subsidiary, Remexian Pharma GmbH.

How did the Canna Cabana loyalty program perform during the second quarter?

The Canna Cabana loyalty membership base grew by 39% compared to the prior year, reaching 2.65 million members. This expansion in the loyalty program remains a core pillar of the company’s retail strategy and customer retention efforts.

What does the new credit facility from the Bank of Montreal mean for High Tide (NASDAQ:HITI)?

High Tide (NASDAQ:HITI) secured C$40 million in senior secured credit facilities from the Bank of Montreal, consisting of a C$25 million revolving facility and a C$15 million delayed draw term loan. These funds are designated to refinance existing high-cost debt and support the company's ongoing capital requirements and growth initiatives.

Has High Tide (NASDAQ:HITI) reached profitability?

Yes, for the three months ended April 30, 2026, High Tide (NASDAQ:HITI) reported positive net income and $1.5 million in free cash flow, marking a shift from previous quarters that recorded losses.

What is the current reach of the Canna Cabana retail network?

As of the end of the second quarter, High Tide (NASDAQ:HITI) operates 228 Canna Cabana retail stores in Canada. The company recently announced the acquisition of four additional Ontario locations from J. Supply Holdings to further consolidate its footprint.

Image for illustrative purposes only. Not a real photo.

High Tide reports record Q2 2026 revenue of $179.3 million

Written by Brie CarterPublished Jun 15, 2026, 8:06 PM

High Tide (NASDAQ:HITI) reported record revenue of $179.3 million for the second quarter of 2026, marking a 30% increase year over year.
Following the earnings release and broader market movement, the High Tide share price closed at $2.25 on June 15, 2026.
The company continues to prioritize expansion through its Canna Cabana loyalty program and international medical cannabis growth via its German subsidiary, Remexian.

High Tide (NASDAQ:HITI) announced its financial results for the three months ended April 30, 2026, highlighting record revenue of $179.3 million and a fourth consecutive quarter of record-breaking performance.

This growth rate represents the company’s fastest expansion in 11 quarters, with the firm also reporting a significant increase in its gross profit to $48.4 million at a 27% gross margin.

Key financial metrics include an adjusted EBITDA of $13.9 million—a 73% increase over the previous year—alongside the successful securing of C$40 million in new senior secured credit facilities from the Bank of Montreal to refinance debt and fund further growth.

High Tide intends to leverage its improved liquidity to continue its retail footprint expansion, which currently includes 228 Canna Cabana locations across Canada.

Following the announcement, the High Tide share price was down 2.6% at $2.25.

High Tide maintains a diversified business model, operating as a leading Canadian cannabis retailer while expanding its international presence through its German medical cannabis subsidiary, Remexian Pharma GmbH.

High Tide reports record Q2 2026 revenue of $179.3 million

Frequently asked questions

Assets related to this article